AmbioPharm

AmbioPharm Inc (API) is a full-service peptide Contract Development and Manufacturing Organisation (CDMO) that caters to the pharmaceutical industry.

AmbioPharm-1.jpeg
AmbioPharm-1.jpeg

Description

AmbioPharm is a U.S.-based contract development and manufacturing organisation (CDMO) that specialises in peptide synthesis and pharmaceutical manufacturing.

Founded in 2004, AmbioPharm offers custom peptide manufacturing services, including solid-phase and liquid-phase peptide synthesis. The company operates from multiple facilities in the U.S. and China, supporting global pharmaceutical and biotechnology clients.

Key products and services:

  • Custom peptide synthesis (solid-phase and liquid-phase)
  • GMP peptide manufacturing
  • Fragment-based peptide synthesis
  • Peptide purification and isolation
  • Full contract manufacturing services

AmbioPharm combines cutting-edge technology with a skilled workforce to meet the growing demand for therapeutic peptides and support the global pharmaceutical supply chain.

Certification
United States FDA, Canada Health Canada, GMP

Capabilities

Contact Information

Website
Address
1024 Dittman Court
Zip/Post Code
29842

The PharmaSource Newsletter

Register today to our free email newsletter for the latest insights into BioPharma outsourcing.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.